PA present the future of drug delivery at the RDD conference

PA Consulting Group presented strategies for successful drug delivery at the recent RDD Drug Delivery conference in Berlin. This included looking at how device development in the future will be impacted by the far- reaching reforms fundamentally changing the relationships between key players across the world of Healthcare. One of the key drivers for the future lies in using information to create more personalised care and standardisation at the same time. This will increase access, drive up quality and reduce the overall cost of care. See PA's Imagine the future of healthcare video below.

PA has a proven track record of delivering inhalation solutions from concept right through to launch and can provide you with all the support you need to achieve the best possible development programme. With more than 25 years of experience of product and process development in the pharmaceutical sector, we remain at the forefront of technological innovation in the field of inhalatory medicine.

Following the success of its respiratory drug delivery technology platform, a US-based inhalation technology company asked PA to advise on its company strategy for the next 10 years.

PA worked with a pharmaceutical client new to medical devices to manage the development project for its innovative pulmonary device.

The SmartJect® autoinjector, developed by PA for Centocor R&D, is the world’s first pre-filled, single use, disposable autoinjector which fully automates the injection cycle. 

For a major pharmaceutical company, PA developed designs to improve the functionality and cost of manufacture of a marketed inhaler.

For a medical service provider, PA developed a remote patient monitoring system.

For a major pharmaceutical company, PA developed compliance monitoring technology onto its inhalation technology.

To discuss how we can support your drug delivery strategy, please contact us now.